What is the bioavailability of this medication?
Edarbi (Azilsartan Medoxomil)
Status:
Open Jan 20, 2025 - 11:14 AM
1answer
Answer
Jan 20, 2025 - 11:14 AM
The bioavailability is 60%. This means that 60% of the drug reaches the systemic circulation, which is significant for determining the effective dose needed to manage blood pressure.
View More Product Details
Edarbi (Azilsartan Medoxomil)
Edarbi is a medication prescribed for treatment of symptoms associated with high blood pressure also known as hypertension. Buy Edarbi online at Canada Pharmacy
Buy Now
View all Edarbi (Azilsartan Medoxomil) Questions & Answers